Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949546 · ClinicalTrials.gov registry record
Treatment of Hidradenitis Suppurativa Using Etanercept
A clinical trial, sponsored by Penn State University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00949546 is a clinical trial that has completed, run by Penn State University. The registered enrollment target is 20 participants.
The verdict
NCT00949546 has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Therapy with etanercept, a TNF inhibitor will reverse the inflammation, symptoms and quality of life and allow healing of HS.
Interventions
- DRUG etanercept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00949546
The ClinicalTrials.gov registry entry for NCT00949546 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which etanercept is the first listed.
NCT00949546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00949546 about?
NCT00949546 is a clinical study titled "Treatment of Hidradenitis Suppurativa Using Etanercept". Therapy with etanercept, a TNF inhibitor will reverse the inflammation, symptoms and quality of life and allow healing of HS.
What is the current status of trial NCT00949546?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-04. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00949546?
The interventions under investigation include: etanercept (DRUG).
Who is sponsoring clinical trial NCT00949546?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.